Table 2.
Articles cited concerning AD and vaccines
| Reference | Title |
|---|---|
| Reed JL Clin Infect Dis. 2012;54(6):832–40.4 | Eczema vaccinatum |
| Schneider L et al. J Allergy Clin Immunol. 2010 Dec;126(6):1306–7.e25 | Immune response to varicella vaccine in children with atopic dermatitis compared with non-atopic controls |
| Beck LA et al. J Allergy Clin Immunol 2009;124(2):260–2696 | Phenotype of atopic dermatitis subjects with a history of eczema herpeticum. |
| Slifka MK et al. J Allergy Clin Immunol. 2014; 133(2): 439–4477 | Transcutaneous yellow fever vaccination of subjects with or without atopic dermatitis |
| Goldstein et al Pediatrics 1975 Mar; 55(3):342–78 | Smallpox vaccination reactions, prophylaxis, and therapy of complications. |
| Lane JM et al 1968. N Engl J Med 1969 Nov 27; 281(22):1201–8.9 | Complications of smallpox vaccination, |
| Lane JM et al. J Infect Dis 1970 Oct; 122(4):303–9.10 | Complications of smallpox vaccination, 1968: results of ten statewide surveys |
| Henderson DA. Emerg Infect Dis 1999 Jul; 5(4):537–9.11 | Smallpox: clinical and epidemiologic features |
| Artenstein AW et al. Expert Rev Vaccines 2008 Oct; 7(8):1225–3712 | Smallpox vaccines for biodefense: need and feasibility |
| Engler RJ et al. J Allergy Clin Immunol 2002 Sep; 110(3):357–65.13 | Smallpox vaccination: risk considerations for patients with atopic dermatitis |
| Vora S et al. Clin Infect Dis 2008 May 15; 46(10):1555–61.14 | Severe eczema vaccinatum in a household contact of a smallpox vaccinee. |
| Howell MD Immunity 2006 Mar; 24(3):341–8.15 | Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus. |
| Copeman P et al. Br Med J 1964;(5414:):906–8.16 | Eczema Vaccinatum. |
| Greenberg RN et al. A PLoS One. 2015 Nov 10;10(11):e014280217 | Multicenter, open-label, controlled phase II study to evaluate safety and immunogenicity of MVA smallpox vaccine (IMVAMUNE) in 18–40 Year old subjects with diagnosed atopic dermatitis |
| Patel DP et al. Vaccine. 2017 Aug 16;35(35 Pt B):4499–4500.18 | Decreased Hepatitis B vaccine response in pediatric patients with atopic dermatitis, psoriasis, and morphea |
| Farooqi IS et al. Thorax. 1998 Nov;53(11):927–32.19 | Early childhood infection and atopic disorder |
| Oszukowska M et al. Postepy Dermatol Alergol. 2015 Dec;32(6):409–20.20 | Role of primary and secondary prevention in atopic dermatitis. |
| Grüber C. Arch Dis Child. 2005 Jun;90(6):553–5.21 | Childhood immunizations and the development of atopic disease. |
| Gehrt L et al. J Allergy Clin Immunol Pract. 2020 Oct 2:S2213-2198(20)31002–3.22 | Timeliness of DTaP-IPV-Hib vaccination and development of atopic dermatitis between 4 months and 1 year of age-register-based cohort study |